Prevalence of disease-related DNA polymorphisms among participants in a large cancer prevention trial

European Journal of Cancer Prevention

Volumn 8, Issue 5, 1999, Pages 441-447

  Woodson, K ^a   Ratnasinghe, D ^a   Bhat, N K ^b   Stewart, C ^b   Tangrea, J A ^a   Hartman, T J ^a   Stolzenberg Solomon, R ^a   Virtamo, J ^c   Taylor, P R ^a   Albanes, D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

ATBC study; Cancer; Genotype; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALCOHOL DEHYDROGENASE; ALPHA TOCOPHEROL; ANDROGEN RECEPTOR; BETA CAROTENE; CELL DNA; DIMETHYLNITROSAMINE DEMETHYLASE; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; ISOENZYME; METHIONINE SYNTHASE; VITAMIN D RECEPTOR;

ARTICLE; CANCER PREVENTION; CANCER RISK; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0033383737     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199910000-00010     Document Type: Article

References (28)

1. Albanes D, Heinonen OP, Taylor PR et al. (1996). Alpha-tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and ' study compliance. J Natl Cancer Inst 88: 1560-70.
2. Ambrosone CB, Freudenheim JL, Graham S et al. (1995). Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 55: 3483-5.
3. ATBC Cancer Prevention Study Group (1994). The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 330: 1029-35.
4. Bosron WF, Li T-K (1986). Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology 6: 502-10.
5. Breast Cancer Linkage Consortium (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62: 676-89.
6. Chen J, Giovannucci E, Kelsey K et al. (1996). Methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56: 4862-4.
7. El-Zein R, Zwischenberger JB, Wood TG, Abdel-Rahman SZ, Brekelbaum C, Au WW (1997). Combined genetic polymorphism and risk for development of lung cancer. Mutation Res 381: 189-200.
8. Finish Cancer Registry (1994). Cancer Incidence in Finland 1992. Cancer Statistics of the National Research and Development Centre for Welfare and Health, Finland.
9. Frosst P, Blom HJ, Milos R et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-3.
10. Giovannucci E, Stampfer MJ, Krithivas K et al. (1997). The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci 94: 3320-3.
11. Glynn SA, Albanes D, Pietinen P et al. (1996). Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 5: 487-94.
12. Harty LC, Caporaso NE, Hayes RB et al. (1997). Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst 89: 1698-705.
13. Hirvonen A, Husgafvel-Pursiainen K, Karjalainen A, Anttila S, Vainio H (1992). Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiol Biomarkers Prev 1: 485-9.
14. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Vainio H (1993). The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis 14: 85-8.
15. Irvine RA, Yu MC, Ross RK, Coetzee GA (1995). The CAG and CGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55: 1937-40.
16. Kato S, Shields PG, Caporaso NE et al. (1992). Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 52: 6712-5.
17. Kelsey KT, Ross D, Traver RD et al. (1997). Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy. Br J Cancer 76: 852-4.
18. Kitson KE, Watanabe J, Eguchi H, Hayashi, S (1995). Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility. Pharmacogenetics 5: S70-S73.
19. London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR (1995). Polymorphism of glutathione S-transferase Ml and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. Natl Cancer Inst 16: 1246-53.
20. Ma J, Stampfer MJ, Giovannucci E et al. (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57: 1098-102.
21. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD (1995). Glutathione-S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4: 89-94.
22. Morita S, Yano M, Shiozaki H et al. (1997). CYP1Al, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 71: 192-5.
23. Probst-Hensch NM, Tannenbaum SR, Chan KK, Coetzee GA, Ross RK, Yu MC (1998). Absence of the glutathione S-transferase Ml gene increases cytochrome P4501A2 activity among frequent consumers of cruciferous vegetables in a Caucasian population. Cancer Epidemiol Biomarkers Prev 7: 635-8.
24. Saarikoski ST, Voho A, Reinikainen M et al. (1998). Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 77: 516-21.
25. Tangrea JA, Helzsouer K, Pietinen P et al. (1997). Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control 8: 615-25.
26. Taylor JA, Hirvonen A, Watson M et al. (1996). Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 15: 4108-10.
27. Van der Put NMJ, Van der Molen EF, Kluitmans LAJ et al. (1997). Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinanemia in neural-tube defects and vascular disease. Q J Med 90: 511-7.
28. Zhong S, Wyllie AH, Barnes D, Wolf CR, Spurr NK (1993). Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast, and colon cancer. Carcinogenesis 14: 1821-4.